Genetic profiles of thyroid cancer shed light on molecular mechanisms.
Researchers look at how mutation status can influence responses to targeted therapy in thyroid cancer.
Most recently, the FDA approved cabozantinib for the treatment of HCC, but this drug has a history.
In late 2015, the American Thyroid Association (ATA) changed guideline recommendations trying to rein in overly aggressive treatment of thyroid cancers that are low risk, offering the choice of hemithyroidectomy as an alternative to total thyroidectomy in these patients. In participating hospitals, the rates of hemithyroidectomy went up.
A new orally active inverse agonist of estrogen-related receptor gamma (ERRү) called DN200434 shows promise with regard to the diagnosis and treatment of anaplastic thyroid cancer.
Alan N. Peiris, MD spoke with ONCOLOGY about guidelines and strategies for treating patients who have had thyroid cancer.
Researchers examined several studies of patients with Graves' Disease to see the prevalence of thyroid cancer in this population.
Naveed Saleh, MD, MS
Researchers surveyed patients who underwent surgery for thyroid cancer and found a high number reported voice abnormalities post-operation.
Anaplastic thyroid cancer (ATC) demonstrates a myriad of genomic alterations, which could represent targets for therapy, according to the results of a study published in Head & Neck.